Immunome, Inc.IMNMNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Latest
-55.91%
↓ 1288% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineDecelerating
Average
-4.03%
Historical baseline
PeriodValue
2025-55.91%
2024-35.50%
20230.00%
20220.00%
2021100.00%
2020-22.76%
2019-18.04%
20180.00%